Together, these results yielded a conceptual model whereby IDO1 acts as a regulatory node at the interface between IFNγ and IL6, shifting the inflammatory microenvironment to a tumor-promoting state by preventing the ability of IFNγ to pare back the tumor neovasculature (Figure 1). Here, IL6 is linked to neoplasm.